Quality Assurance and Quality Management in Pharmaceutical Science and Pharmaceutical Industry by Kushare, Swati et al.
Kushare et al                                                                                                          Journal of Drug Delivery & Therapeutics. 2019; 9(2-s):537-542 
ISSN: 2250-1177                                                                                  [537]                                                                                 CODEN (USA): JDDTAO 
Available online on 15.04.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                                   Review Article 
Quality Assurance and Quality Management in Pharmaceutical Science and 
Pharmaceutical Industry 
Kushare Swati 1*, Darekar Avinash 1, Saudagar Ravindranath2 
1 Department of Pharmaceutics, R.G. Sapkal College of Pharmacy, Anjaneri, Nashik, Maharashtra, India- 422 213 
2 Department of Pharmaceutical Chemistry, R.G. Sapkal College of Pharmacy, Anjaneri,     Nashik, Maharashtra, India- 422 213 
 
ABSTRACT 
Affection affirmation (QA) is aimed at ensuring affection analysis results. The purpose of affection affirmation is to accord relevant, reliable, 
appropriate analysis after-effects which are interpreted correctly. Affection affirmation involves activities both central and alfresco laboratory, 
acceptable class convenance and able administration skill. The WHO analogue of affection affirmation is a absolute action area by the affection of 
lab letters can be guaranteed. I capital to animadversion on the beat entitled, “An in-flight absorption on affirmation and quality.”The acreage of 
Affection Administration has abounding methods to abate and anticipate defects in any industry. Some of the best accepted methods today are 
Six Sigma, Lean Enterprise, and Benchmarking. There is a abundance of accurate affirmation to appearance how these methods accept helped the 
bloom affliction industry even out defects, waste, basis causes, and optimal solutions, application anarsenal of administration tools. 
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INTRODUCTION 
The World Health Organization defines Affection Ascendancy 
(QC) as “the accession of all procedures undertaken to 
ensure the character and abstention of a accurate 
pharmaceutical.”The purpose of QC is to ensure the 
assurance and ability of a accomplished biologic artefact 
afore it is appear to the public. Supporting affection systems 
charge to ascertain whether items such as raw materials, 
components, containers, labeling and packaging abort to 
accommodated above-mentioned specifications. The QC 
Department is amenable for administering this assignment 
as able-bodied as testing the accomplished artefact to ensure 
it meets authoritative requirements. For pharmaceuticals, 
Affection Ascendancy may absorb analytic procedures 
alignment from simple actuality screenings to circuitous 
pharmacopoeia monographs. biologic manufacturers of the 
accepted of articles actuality fabricated and sold, but QC 
abandoned cannot agreement that a aerial affection artefact 
will be consistently produced. Substantial accomplishment 
decay (time and abstracts as a aftereffect of action 
deviations) and post-market recalls are affirmation of this. A 
bigger access is bare as the FDA accede in their 2006 
Guidance for Industry, Affection Systems Access to Biologic 
Current Good Accomplishment Practice Regulations stated, 
“Quality should be congenital into the product, and testing 
abandoned cannot be relied on to ensure artefact quality.” 
Affection Assurance (QA) involves demography a proactive 
access to ensure biologic articles are fabricated in 
accordance with accomplishment standards and met their 
pre-defined artefact specifications. The aim is for affection 
and acquiescence to be accomplished “right the aboriginal 
time” rather than depend on audition problems. The aim is to 
always advance accomplishment standards, eliminating 
errors forth the way. Affection ascendancy role to play, but 
with able QA and reliable operational achievement during 
the process, it becomes a basic of the biologic affection 
system.1,2 
Quality Assurance 
The responsibilities of affection affirmation include: 
• Products advised for accessible are safe, effective, and 
adapted as to dosage. 
• Predetermined affection standards are upheld back 
allotment and accepting articles from suppliers. 
• Recall action is affiliated and able for defects inpost-market 
products. 
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• Post-market communications are accessible for public 
concerns and questions. 
• Objectives of Biologic QA 
• Offering the affirmation that a healthcare able prescribing 
or administrate the biologic is assured of anniversary unit’s 
efficacy. 
• Attention the accessible adjoin abeyant hazards acquired 
by adventitious accomplishment and architecture defects, or 
instructions for artefact usage/storage space. 
• Making abiding of complete acquiescence with applicative 
industry regulations, statutes, laws and guidelines. 
• Attention the artefact and architect adjoin penalties, 
abrogating publicity, accident of credibility, budgetary 
losses, etc. 
 Importance of QA in Pharmaceuticals 
 The aliment industry, adherence to all-embracing affection 
standards is important for the pharma and biotech sectors 
because of the absolute affiliation amid artefact affection and 
accessible health/safety. Defects in biologic drugs accession 
the accident of compromising chump bloom and potentially 
beastly or beastly activity as well. 
Effective affection affirmation helps organizations body 
bigger believability and chump confidence, in accession to 
advancement adherence to FDA regulations and 
convalescent assembly ability and processes. It reduces the 
affairs of abrogating publicity and appulse on sales as able-
bodied (e.g. if a accomplished artefact were to be recalled 
due to affection defects). 
Hence, affection affirmation in the biologic industry offers 
amazing allowances in agreement of ascent profits and a 
stronger reputation. However, through the lifecycle of a new 
drug, every aspect of the assembly action needs to be taken 
into consideration, whether it alone or collectively impacts 
artefact quality. 
How Does a Biologic QA Administration Work? 
Most companies set up abstracted QA departments, with the 
absorbed to acquisition and actual defects in the 
development date (before the final artefact is accessible to 
hit the market). 
• Here’s an overview of QA’s role:  
• Development Date – During R&D, blockage the 
accomplishment of raw material, vendors, testing methods, 
validation, certificate control, accessories arrangement and 
operating procedures, cadre application and training, 
abstracts recording, analytic trials, conception of API batches 
and more. 
• Manufacturing Date – These are a few examples of the QA 
unit’s role during production: 
• Preparing, acknowledging and ecology the accomplishing 
of key abstracts (Quality Policy and Objectives, Affection 
Manual, Validation Master Plan, etc.). 
 Acknowledging an accessories calibration, accomplishment 
and aliment schedule, as able-bodied as analytical utilities 
accomplishment agenda (HVAC, water, gas and ability 
administration systems, etc.). 
Ensuring that blueprint and analysis procedures for raw 
materials, packing materials, in-process testing, APIs, 
adherence testing, etc. are all in place. 
 Reviewing training annal to analysis if on-the-job and 
consecration training is demography abode according to the 
schedule, and whether QC (Quality Control) analysts are 
actuality validated. 
 Ensuring that planned/unplanned changes or deviations are 
documented, advised and analyzed, and advising studies, 
tests or validation activities to be performed. 
 Logging and responding to chump complaints, authoritative 
the analysis into the account of the issue, accouterment an 
assay address to the customer, etc. 
Initiating, documenting and investigating bazaar returns, 
reprocessing (for API batches) or abolition (for 
accomplished batches), and allegorical authoritative 
authorities about defects begin afterwards distribution. 
Training and arch the centralized analysis aggregation for 
anniversary department collaborate with auditors during 
external, centralized and chump inspections, and intimating 
administration of the observations. 
 Reviewing and acknowledging accomplishment annal and 
QC testing abstracts afore any intermediate, API or 
accomplished accumulation is released, as able-bodied as 
alternate trending of this data. 
 Initiating an OOS (out of specification) analysis and 
reviewing the QC analysis if any raw material, packaging, 
average or adherence sample does not accommodated 
accustomed and accustomed blueprint during the latter. 
Qualifying and auditing arrangement account providers for 
tests and calibrations not performed in-house, reviewing and 
advancing Affection and Technical agreements for added 
accomplishment sites. 
QA System: The Backbone of Pharma Quality  
• While the development, accomplishment and business of 
articles may absorb added than one assemblage or 
department, the affection assemblage is usually absolute of 
assembly processes. 
• You could additionally use specialized departments 
congenital in an authoritative arrangement to handle the 
affection arrangement and its accompanying duties. In such a 
scenario, the QA assemblage would booty on the assignment 
of accessories acceptable systems as able-bodied as defining 
them in SOPs (standard operating procedures) and college 
akin instructions. 
• Delegating QA functions and controlling ascendancy to 
operation departments and cadre is ideal for beyond 
organizations, to advice ensure affection on the floor. Top-
level administration additionally needs to be complex in the 
responsibilities of this unit, which may be a aggregate of QA 
and QC. 
Good convenance for QA procedures requires an cold 
analysis to appraise the affection of the inventory, and 
additionally to analyze areas area improvements could be 
made. The account may be advised as a accomplished or in 
parts. QA procedures are utilized in accession to the Tier 1 
and Tier 2 QC. The cold in QA accomplishing is to absorb 
reviewers that can conduct an aloof analysis of the inventory. 
It is acceptable convenance to use QA reviewers that accept 
not been complex in advancing the inventory. Preferably 
these reviewers would be absolute experts from added 
agencies or a civic or all-embracing able or accumulation not 
carefully affiliated with civic account compilation. Area third 
affair reviewers alfresco the account bureau are not 
available, agents from addition allotment of the account 
bureau not complex in the allocation of the account actuality 
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advised can additionally fulfil QA roles. It is acceptable 
convenance for account agencies to conduct a basal able 
associate analysis (Tier 1 QA) above-mentioned to account 
acquiescence in adjustment to analyze abeyant problems and 
accomplish corrections area possible. It is additionally 
acceptable convenance to administer this analysis to all 
antecedent categories in the inventory. However, this will 
not consistently be applied due to timing and ability 
constraints. Key antecedent categories should be 
accustomed antecedence as able-bodied as antecedent 
categories area cogent changes in methods or abstracts 
accept been made. Account agencies may additionally accept 
to accomplish added all-encompassing associate reviews or 
audits or both as added (Tier 2) QA procedures aural the 
accessible resources.3 
Quality management   
The  abstraction  of  accepted biologic affection 
administration arrangement is based on a internationally 
harmonized advice ICH Q10 , which is developed by the 
Expert Working Group (Quality) of the International 
Conference on Harmonization of Technical Requirements for 
Registration of Pharmaceuticals for Human Use and USFDA 
and in final phases for acceptance by the authoritative bodies 
of the European Union, Japan, and the United States is which 
describes a archetypal for a biologic affection arrangement 
that encourages the use of science- and risk-based 
approaches and can be implemented throughout the altered 
stages of a artefact lifecycle.  
Pharmaceutical affection administration system 
It is applicative to biologic products, including biotechnology 
and biological products, throughout the artefact lifecycle the 
systems acknowledging the development and manufacture 
of biologic biologic substances. It includes 
 1. Biologic Development  
A. Accomplishment and development of APIs. 
B. Manufacture of medical kits and accessories for 
investigation. 
C. Development of medical commitment systems. 
D. Pilot bulb scale-up activities. 
E. Accomplishment activity of formulation. 
F. Development of medical devises for authentic dosing. 
2. Analytical adjustment development. 
A. During accomplishment process. 
• Acquisition and ascendancy of materials. 
• Provision of facilities, utilities, and equipment. 
• Production (including packaging and labeling) 
• Affection ascendancy and assurance. 
• Release. 
• Storage. 
B. During artefact technology transfer. 
C. During artefact discontinuation 
• Retention of sample and accompanying documentation 
• Continued artefact appraisal and reporting 
Objectives: 
Three capital objectives are as follows: 
1. Achieve Artefact Realization 
2. Able ascendancy over variables 
3. Continuous Advance 4-7 
Elements of Biologic Affection System: 
Fundamental elements for able biologic affection systems are 
as follows: 
• Managerial analysis of activity achievement and artefact 
quality 
• Activity achievement and artefact affection ecology system 
• Corrective activity and antitoxin activity (CAPA) system 
• Change ascendancy administration system.8  
Quality Administration of biologic contempo approaches 
and advancement.  
 Affection administration is administration of assorted 
sectors to ensure acceptable affection of the product. 
Affection administration abide of four capital apparatus i.e. 
Affection planning, Affection control, Affection assurance, 
Affection advance 9 . The outline of affection administration 
arrangement is accustomed in  Outline of Affection 
administration arrangement Fig. 1 Practices afore TQM 
Practices afore TQM Afore actuality of TQM, acceptable 
affection administration tools, alone included final artefact 
affection ascendancy (FPQC) and on base of these affection 
ascendancy tests, it was assured that whether artefact 
acquired is of adapted affection or not. If all ambit of final 
artefact were begin to be aural limit, again it was advised as 
affection artefact but if after-effects were begin to be out of 
blueprint again artefact was said to be of poor affection and 
rejected. Capital drawbacks of acceptable methods were that 
they do not accommodate any activity or accomplish for 
affection administration of artefact during the process. Alone 
affection ascendancy administration was amenable for 
affection of the product, added departments were accepting 
no affair with the quality, which usually aftereffect in batch-
to-batch variability.10,11 
Quality accident management’ is authentic as a adjustment 
for the assessment, control, advice     and assay of risks to the 
affection of the biologic (medicinal) artefact through the 
artefact lifecycle area decisions can action at any point in the 
process. It is a broadly acclimated administration apparatus 
acclimated in biologic industry, which involves analytical 
action for identification, assay and ascendancy of accident 
complex in any advancing action in the industry .Various 
genitalia included in affection accident administration.
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Figure 1: Quality Management 
 
Quality accident administration includes     
• Identification of risks: It involves identification of risks of 
risks afore they become austere to be solved. 
• Assay of data: It involves assay of accident abstracts Assay 
of abstracts that and classifying the risks based on their 
appulse and priority. 
• Planning: Based on assay of accident abstracts planning or 
acknowledgment of risks complex and authoritative 
decisions how to abate risks.                                                                                                            
• Track: Monitor the affairs for accident acknowledgment 
and al Track so ecology accident indicators.                        
• Control: It involves austere ascendancy over accident 
Ascendancy acknowledgment plan to abstain aberration 
from these plans.                                                                                                                                                                        
• Communication: It involves advice of Advice 
acknowledgment about affection accident administration 
plans, their account in acknowledgment of risks and about 
award the arising risks. 12,13 
Current cachet  
TQM is best broadly acclimated affection administration 
access worldwide. But it is not acclimated broadly in Indian 
biologic industry. India is one of the better producers of 
pharmaceuticals in the apple with about 20% of absolute 
assembly of pharmaceuticals artefact in the world. The 
capital acumen for belted appliance of  TQM in India is that, 
cardinal of baby calibration companies is added than the 
cardinal of bunch companies .Further added the cardinal of 
WHO-GMP or US-FDA certified industries is actual beneath in 
India. These baby calibration industries adopt to consign to 
poor countries such as African countries because of 
abridgement of affection products. The capital acumen for 
poor affection is abridged appliance of affection 
administration approaches such as TQM.14 
TQM: The Concept and Approaches 
TQM is a accumulated accomplishment advised by alignment 
to advance affection at every level. TQM is about affair 
affection expectations as authentic by the customer; this is 
alleged customer-defined quality. 
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 Figure 2: Total Quality Management 
 
Approaches for TQM 
Various approaches as accomplished by industries in TQM of 
biologic action are:   
These are set of accoutrement or techniques acclimated for 
action advance or affection administration of process. Six 
Sigma address can advance the affection of action outputs by 
anecdotic and removing the causes of errors and aspersing 
air headedness in accomplishment and business processes 
15-17 
 Management responsibility:       
 Leadership is capital to authorize and advance a Company 
advanced charge to affection and for the achievement of the 
pharmaceutical quality system. Administration has the 
albatross to accomplish affection accompanying goals as per 
the affection policy. There charge be a bright compassionate 
and actual set of authority and albatross at all levels 
including alone and aggregate role. Strict charge against the 
affection objectives should be demonstrated. Management 
should participate in the design, implementation, 
monitoring, and aliment of an effective  biologic affection 
system. Affection audits should be performed periodically for 
adapted advance in action performance. Training needs of 
staff should be finer articular and chase up arrangement 
should be accustomed to ensure able training. Adequate 
ability management, able communication between all levels 
of administration and journal assay of the affection 
arrangement helps to achieve adapted biologic affection 
arrangement governance.                                                        
Continuous advance in action achievement and artefact 
quality:                                                                                       
 artefact affection depends on adapted architecture of 
affection attributes during artefact development phase. 
Abstruse ability or specification, ascendancy action and 
validation approaches should be finer transferred aural or 
amid accomplishment sites for bartering manufacturing. 
Artefact cessation aspects accommodate assimilation of 
accordant documents, samples and assay of artefact 
assessment, complaint administration and adherence 
accompanying problems as per authoritative provisions. 18-20 
 Objectives of affection administration arrangement may 
be accomplished by afterward means: 
A. Ability Management 
B. Affection Accident Management 
The abstruse aspects of the process, abnormality of the 
artefact architecture and problems during artefact activity 
cycles helps to actualize a ability database and should be 
systematically documented. ICH Q9 provides attempt and 
examples of accoutrement for quality accident 
administration and access to identifying, scientifically 
evaluating and controlling abeyant risks to quality. 
Innovation, around-the-clock advances the outputs of 
process achievement and artefact affection ecology and 
CAPA drive changes. It facilitates around-the-clock advance 
of action achievement and artefact quality throughout the 
artefact lifecycle. Developing a new biologic affection 
arrangement or modifying an absolute one requires accurate 
appraisal of admeasurement and complexities of the 
Kushare et al                                                                                                          Journal of Drug Delivery & Therapeutics. 2019; 9(2-s):537-542 
ISSN: 2250-1177                                                                                  [542]                                                                                 CODEN (USA): JDDTAO 
company’s activity; Identification of administration 
responsibilities; systems, responsibility and blueprint for 
arrangement accomplishment activities; Change control 
measures; identification and enactment of achievement 
indicators. Affection riskmanagement action should analyze 
attributes for altitude and assay of state of ascendancy with 
assorted approaches including statistical indicators. 21 
CONCLUSION  
The term quality cannot be confined to one definition. It is 
tensile in nature and people define it in their own ways but 
one thing is common in all and that is satisfaction. 
Manufacturer is satisfied if the product meets it specification 
and consumer is happy when the particular product fulfils 
his need. But in anyways Quality is unavoidable thing today 
and one cannot ignore it. When it comes in context of 
Pharma then Quality is a legal issue and must be maintained 
in pharmaceutical products. The present paper focuses on 
some aspects and need of maintaining Quality in Pharma 
through Quality Management System. 
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